Answers are grounded in this paper and cite their sources.
IF measurements of bone mass are to be clinically useful, they must be safe, precise, accurate, and of reasonable cost in relation to the information provided. Since when bone mass is low the clinical outcome of concern is fracture, there must be a demonstrated relation between the measurement and the subsequent risk of fracture. The information provided must be helpful to the clinician in making a decision to intervene or not; and if a therapeutic regimen is chosen, it must have a positive influence on health (e.g., a reduction in the incidence of fractures) without an unreasonable increase in other . . .
No takes yet. Share an insight, caveat, or question.
Desforges et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: